Export 90 results:
Author Title [ Type(Desc)] Year
Filters: Author is Cruz, F.  [Clear All Filters]
Book
Charrua, A., Avelino, A., & Cruz, F. (2011). Modulation of urinary bladder innervation: TRPV1 and botulinum toxin A. Handbook of Experimental Pharmacology (Vol. 202, pp. 345 - 374).
Book Chapter
Avelino, A., Cruz, F., Panicker, J. N., & Liechti, M. D. (2016). Basic principles. In Practical Functional Urology (pp. 1 - 17).
Charrua, A., & Cruz, F. (2015). Intravesical Capsaicin and Resiniferatoxin for Bladder Disorders. In TRP Channels as Therapeutic Targets: From Basic Science to Clinical Use (pp. 119 - 127).
Journal Article
Cruz, C. D., Ferreira, D., McMahon, S. B., & Cruz, F. (2007). The activation of the ERK pathway contributes to the spinal c-fos expression observed after noxious bladder stimulation. Somatosensory and Motor Research, 24(1-2), 15 - 20.
Dinis, P., Charrua, A., Avelino, A., Yaqoob, M., et al. (2004). Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis. Journal of Neuroscience, 24(50), 11253 - 11263.
Tomada, N., Tomada, I., Botelho, F., Cruz, F., & Vendeira, P. (2011). Are all metabolic syndrome components responsible for penile hemodynamics impairment in patients with erectile dysfunction? The role of body fat mass assessment. Journal of Sexual Medicine, 8(3), 831 - 839.
Antunes-Lopes, T., Coelho, A., Pinto, R., Barros, S. C., et al. (2017). Author Reply. Urology, 99, 55 - 56.
Coelho, A., Antunes-Lopes, T., Gillespie, J., & Cruz, F. (2017). Beta-3 adrenergic receptor is expressed in acetylcholine-containing nerve fibers of the human urinary bladder: An immunohistochemical study. Neurourology and Urodynamics, 36(8), 1972 - 1980.
Antunes-Lopes, T., Carvalho-Barros, S., Cruz, C. - D., Cruz, F., & Martins-Silva, C. (2011). Biomarkers in overactive bladder: A new objective and noninvasive tool?. Advances in Urology.
Cruz, C. D., Coelho, A., Antunes-Lopes, T., & Cruz, F. (2015). Biomarkers of spinal cord injury and ensuing bladder dysfunction. Advanced Drug Delivery Reviews, 82, 153 - 159.
Dinis, P., Silva, J., Ribeiro, M. J., Avelino, A., et al. (2004). Bladder C-fiber desensitization induces a long-lasting improvement of BPH-associated storage LUTS: A pilot study. European Urology, 46(1), 88 - 94.
Laterza, R. M., Sievert, K. - D., de Ridder, D., Vierhout, M. E., et al. (2015). Bladder function after radical hysterectomy for cervical cancer. Neurourology and Urodynamics, 34(4), 309 - 315.
Matos, R., Cordeiro, J. M., Coelho, A., Ferreira, S., et al. (2016). Bladder pain induced by prolonged peripheral alpha 1A adrenoceptor stimulation involves the enhancement of transient receptor potential vanilloid 1 activity and an increase of urothelial adenosine triphosphate release. Acta Physiologica, 218(4), 265 - 275.
Silva, C., Silva, J., Castro, H., Reis, F., et al. (2007). Bladder sensory desensitization decreases urinary urgency. BMC Urology, 7.
Cruz, F., & Silva, C. (2004). Botulinum toxin in the management of lower urinary tract dysfunction: Contemporary update. Current Opinion in Urology, 14(6), 329 - 334.
Frias, B., Allen, S., Dawbarn, D., Charrua, A., et al. (2013). Brain-derived neurotrophic factor, acting at the spinal cord level, participates in bladder hyperactivity and referred pain during chronic bladder inflammation. Neuroscience, 234, 88 - 102.
Charrua, A., Pinto, R., Taylor, A., Canelas, A., et al. (2015). Can the adrenergic system be implicated in the pathophysiology of bladder pain syndrome/interstitial cystitis? A clinical and experimental study. Neurourology and Urodynamics, 34(5), 489 - 496.
Tomada, N., Tomada, I., Cruz, F., Vendeira, P., & Neves, D. (2010). Characterization of VEGF and angiopoietins expression in human corpus cavernosum during aging. Journal of Sexual Medicine, 7(4 PART 1), 1410 - 1418.
Charrua, A., Cruz, C. D., Jansen, D., Rozenberg, B., et al. (2015). Co-administration of transient receptor potential vanilloid 4 (TRPV4) and TRPV1 antagonists potentiate the effect of each drug in a rat model of cystitis. BJU International, 115(3), 452 - 460.
Chapple, C. R., Cruz, F., Deffieux, X., Milani, A. L., et al. (2017). Consensus Statement of the European Urology Association and the European Urogynaecological Association on the Use of Implanted Materials for Treating Pelvic Organ Prolapse and Stress Urinary Incontinence. European Urology, 72(3), 424 - 431.
Silva, J., Silva, C. M., & Cruz, F. (2014). Current medical treatment of lower urinary tract symptoms/BPH: Do we have a standard?. Current Opinion in Urology, 24(1), 21 - 28.
Charrua, A., Reguenga, C., Paule, C. C., Nagy, I., et al. (2008). Cystitis is associated with TRPVIb-downregulation in rat dorsal root ganglia. NeuroReport, 19(15), 1469 - 1472.
Dinis, P., Charrua, A., Avelino, A., Nagy, I., et al. (2005). The distribution of sensory fibers immunoreactive for the TRPV1 (capsaicin) receptor in the human prostate. European Urology, 48(1), 162 - 167.
Coelho, A., Dinis, P., Pinto, R., Gorgal, T., et al. (2010). Distribution of the High-Affinity Binding Site and Intracellular Target of Botulinum Toxin Type A in the Human Bladder. European Urology, 57(5), 884 - 890.
De Carvalho, T. G. R., Pinto, R., Cruz, F., & Silva, J. (2016). Effect of onabotulinum toxin type a intraprostatic injection on the outcome of benign prostatic hyperplasia patients refractory to medical therapy: A 2-year follow-up study. Archivos Espanoles de Urologia, 69(10), 719 - 726.

Pages


Home | Site Map | Contacts | Credits | Privacy & Cookies | Intranet | Social Networks |


rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 220 408 800 | email: info@ibmc.up.pt | © copyright 2010 ibmc